a Institute of Medical Microbiology, Semmelweis University, Box 370, H-1445 Budapest; b Phage Laboratory of the Budapest Institute of the National Public Health and Medical Officer Service, Budapest; c Pál Heim Municipal Children's Hospital of Budapest, Budapest, Hungary
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The aim of this study was to examine the incidence of resistance to penicillin, cefotaxime and levofloxacin in respiratory tract isolates of S. pneumoniae.
Levofloxacin activity against S. pneumoniae has been found not to be associated with penicillin susceptibility determined by either the MIC or the bactericidal index and so levofloxacin has been suggested as potential therapy for infections.2 This prompted us to assess the correlation between MICs of penicillin, cefotaxime and levofloxacin for penicillin-non-susceptible respiratory tract isolates of S. pneumoniae.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Samples, except sputa, were taken in Mast transport medium with small swabs (Mast Diagnostica, Reinfeld, Germany) from the eyes and middle ears; the Biotest Transport System with normal sized swabs (Biotest, Dreieich, Germany) was used for other sites. Culture was carried out on 5% sheep blood agar and chocolate agar plates in 5% CO2 at 3537°C for 2448 h. S. pneumoniae isolates were identified as described by Ruoff.3 Repeat isolates from individual patients were excluded. The presence of some capsular antigens was tested by Slidex Pneumo latex agglutination reagent (bioMérieux, Lyon, France). S. pneumoniae ATCC 49619 was used as control. Strains were stored in a Mast Microbank System at 80°C.
Susceptibility testing to appropriate antimicrobials was carried out by the disc diffusion method4 with Oxoid discs. Penicillin resistance in S. pneumoniae isolates was screened using 1 µg oxacillin discs (Oxoid, Basingstoke, UK) and strains showing 20 mm inhibition zones were assessed as susceptible. Strains exhibiting smaller inhibition zones around the 1 µg oxacillin discs were provisionally identified as penicillin non-susceptible4 and further examined by low concentration penicillin Etest (AB Biodisk, Solna, Sweden). The results were interpreted as described previously.5 Respiratory strains with penicillin MICs of 0.125 mg/L or higher were further tested for cefotaxime and levofloxacin susceptibility according to the protocol of the EARSS.6
We attempted to apply a linear regression analysis as described by Brueggemann et al.7, but the distribution of MICs of penicillin, cefotaxime and levofloxacin for the S. pneumoniae strains did not correspond to a normal distribution. Instead, therefore, the Spearman rank correlation coefficients were calculated from the MIC data using the software Statistica for Windows, v. 4.5.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Disc diffusion tests showed that 64, 54, 71, 96, 48 and 100% of strains were susceptible to oxacillin, erythromycin, tetracycline, chloramphenicol, sulfamethoxazole/trimethoprim and glycopeptides, respectively. One-hundred and twenty (36.7%) of 327 strains were designated as penicillin non-susceptible with 1 µg oxacillin.
MIC determination for these strains by Etest identified an additional 19 strains as penicillin susceptible (PS) (Figure 1). The NCCLS defines S. pneumoniae strains as PS, penicillin intermediate (PI) and penicillin resistant (PR) if the MICs are
0.1, 0.121.5 and
2.0 mg/L, respectively. Thus, the overall incidence of PS stains was 69.1%. Overall 71 strains (21.7%) showed intermediate and 30 (9.2%) had full resistance to penicillin. Twenty-eight (93.3%) of the 30 PR strains and 68 (95.8%) of the 71 PI strains were isolated from the respiratory tract.
|
|
Seven (7.3%) of the 96 penicillin-non-susceptible strains had intermediate and four (4.2%) had high-level resistance to levofloxacin according to NCCLS criteria (Figure 2b). However, levofloxacin plasma concentrations are close to its MIC for pneumococci. According to BSAC guidelines strains with MICs
4 mg/L levofloxacin are considered resistant. Strains with this MIC were over-represented in the groups with penicillin MICs > 32 mg/L, so an assumption that highly penicillin/cefotaxime-resistant strains are not levofloxacin resistant depends on the breakpoints chosen. According to BSAC guidelines, four of the PI and four of the PR strains (overall 8.3%) should be considered levofloxacin resistant. Strains isolated from the LRT had considerably higher MICs of both antimicrobials.
The four high-level levofloxacin-resistant stains (MIC 32 mg/L) were isolated from sputum of in-patients of the Department of Pulmonology, Semmelweis University, Budapest, where levofloxacin has been administered since the autumn of 1999. These strains were penicillin intermediate and remained susceptible to cefotaxime, carbapenems and glycopeptides.
There were 12 strains with extremely high levels of penicillin and/or cefotaxime resistance isolated from the respiratory tract of children under 6 years of age. Most of these had high-level resistance to carbapenems too, and needed increased concentrations of vancomycin within the susceptible range to inhibit their growth. Eight of these strains were susceptible and four were intermediately susceptible (NCCLS guidelines) or resistant (BSAC guidelines) to levofloxacin.
Based on the NCCLS interpretations, increased penicillin resistance in S. pneumoniae strains strongly correlated with increased cefotaxime resistance as the Spearman r proved to be 0.89, P < 0.001. A weak correlation was found between MICs of ß-lactams and levofloxacin as the Spearman r proved to be 0.37, P < 0.001 and 0.45, P < 0.001 between penicillin and levofloxacin, and cefotaxime and levofloxacin, respectively.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The 1 µg oxacillin disc diffusion test has overestimated the prevalence of penicillin resistance in S. pneumoniae, and so, we advise that penicillin MIC determinations are carried out on all clinically significant S. pneumoniae isolates as the first susceptibility test.
Cefotaxime-resistant S. pneumoniae strains have emerged in Hungary; this may be attributable to the introduction, and frequent administration of oral cephalosporins in general practice as well as ceftriaxone use. Smith & Klugman10 analysed the penicillin-binding proteins (PBPs) of some other high-level resistant Hungarian isolates and found them to be clonal. In the hospitals where our patients were treated, penicillin and piperacillin have been used frequently and may be selectors for altered PBP 2B, which leads to high-level cefotaxime resistance.10 The fact that all but two of the 28 PR strains showed intermediate or full resistance to cefotaxime, and that most of the penicillin and cefotaxime highly resistant isolates were also resistant to carbapenems indicates potential for the selection of penicillin-cephalosporin-carbapenem cross-resistant strains of S. pneumoniae.
Under these conditions the therapeutic role of levofloxacin has been appreciated and the question of associated resistance to the ß-lactams is of great importance.2 Although the correlation analysis on MICs of penicillin, cefotaxime and levofloxacin for the strains studied indicates a weak association between the two types of resistance, no levofloxacin-intermediate or -resistant strain proved to be PS. Six were PI and five were PR. Fluoroquinolones have been widely used in Hungary in hospitals and general practice; therefore, it is not surprising that in as little as 6 months after introducing levofloxacin in the Department of Pulmonology resistant strains have appeared.
![]() |
Acknowledgements |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Notes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
2 . Thornsberry, C., Ogilvie, P. T., Holley, H. P. & Sahm, D. F. (1998) In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance. Clinical Therapeutics 20, 117990.
3 . Ruoff, K. (1995). Streptococcus. In Manual of Clinical Microbiology, 6th edn, (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds) pp. 299307. ASM Press, Washington, DC.
4 . National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A7. NCCLS, Wayne, PA.
5 . National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobal Susceptibility Test for Bacteria that Grow AerobicallyFifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA.
6 . Goettsch, W., Bronzwaer, S. L. A. M., de Neeling, A. J., Wale, M. C. J., Aubry-Damon, H., Olsson-Liljequist, B. et al. (2000). Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS). Clinical Microbiology and Infection 6, 5963.
7
.
Brueggemann, A. B., Pfaller, M. A. & Doern, G. V. (2001). Use of penicillin MICs to predict in vitro activity of other ß-lactam antimicrobal agents against Streptococcus pneumoniae. Journal of Clinical Microbiology 39, 3679.
8 . Marton, A., Gulyas, M., Munoz, R. & Tomasz, A. (1991). Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. Journal of Infectious Diseases 163, 5428.[ISI][Medline]
9 . Marton, A. (1995). Epidemiology of resistant pneumococci in Hungary. Microbial Drug Resistance 1, 12730.[ISI][Medline]
10 . Smith, A. M. & Klugman, K. P. (2000). Non-penicillin-binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae. Microbial Drug Resistance 6, 10510.[ISI][Medline]
Received 27 March 2001; returned 11 June 2001; revised 16 July 2001; accepted 22 August 2001